Ifp Advisors, Inc Harmony Biosciences Holdings, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$30.8 - $53.92 $11,180 - $19,572	-363 Reduced 93.56%	25 $0
Q4 2022 Feb 07, 2023	SELL	$45.4 - $60.91 $27,739 - $37,216	-611 Reduced 61.16%	388 $21,000
Q3 2022 Nov 08, 2022	BUY	$42.06 - $55.45 $13,963 - $18,409	332 Added 49.78%	999 $45,000
Q2 2022 Sep 06, 2022	BUY	$33.54 - $52.15 $22,371 - $34,784	667 New	667 $32,000
Q2 2022 Aug 12, 2022	SELL	$33.54 - $52.15 $22,371 - $34,784	-667 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$33.14 - $51.13 $17,961 - $27,712	542 Added 433.6%	667 $32,000
Q1 2022 Aug 08, 2022	BUY	$33.14 - $51.13 $4,142 - $6,391	125 New	125 $6,000

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.